JANSSEN DURAGESIC FENTANYL TRANSDERMAL PATCH APPROVED FOR CHRONIC PAIN, ONE WEEK AFTER NDA DAY; J&J R&D PARTNER ALZA WILL CO-PROMOTE TO ONCOLOGISTS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".